FALSE000081772000008177202026-11-172026-11-17
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
_______________________________________________________
FORM 8-K
________________________________________________________
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 17, 2026
________________________________________________________
SYNAPTICS INCORPORATED
(Exact name of Registrant as Specified in Its Charter)
________________________________________________________
| | | | | | | | |
| Delaware | 000-49602 | 77-0118518 |
(State or Other Jurisdiction of Incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
| | |
| 1109 McKay Drive | | |
San Jose, California | | 95131 |
| (Address of Principal Executive Offices) | | (Zip Code) |
Registrant’s Telephone Number, Including Area Code: (408) 904-1100
________________________________________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| | | | | |
| o | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
| o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| |
| o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| |
| o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| | | | | | | | | | | | | | |
Title of each class | | Trading Symbol(s) | | Name of each exchange on which registered |
| Common Stock, par value $0.001 per share | | SYNA | | NASDAQ Global Select Market |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company o
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
ITEM 5.07. Submission of Matters to a Vote of Security Holders.
On November 17, 2026, Synaptics Incorporated (the “Company,” “we” or “us”) held a special meeting of our stockholders (the “Special Meeting”) to vote on three proposals described in the Company’s definitive proxy statement filed with the U.S. Securities and Exchange Commission on October 19, 2026, and mailed to the Company’s stockholders on or about October 19, 2026 (the “Proxy Statement”). As of the close of business on the record date of October 13, 2026, there were 39,701,387 shares of the Company’s common stock, par value $0.001 per share (“Shares”), outstanding and entitled to vote at the Special Meeting. The number of Shares present at the beginning of the Special Meeting, in person or by proxy, was 31,734,706 or 79.93% of the Shares outstanding and entitled to vote at the Special Meeting. At the Special Meeting, the following proposals were presented to our stockholders, with the final voting results indicated below:
Proposal One: Merger Proposal. Our stockholders adopted the Amended and Restated Agreement and Plan of Merger, dated October 1, 2026, as it may be amended from time to time, by and among ON Semiconductor Corporation, a Delaware corporation (“onsemi”), Sonic Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of onsemi (“Merger Sub”), and the Company, which provides, among other things, that subject to the satisfaction or waiver of the conditions set forth therein, at the effective time, Merger Sub will merge with and into the Company, with the Company surviving as a wholly-owned subsidiary of onsemi (the “Merger”).
| | | | | | | | |
| For | Against | Abstain |
| 31,209,141 | 510,842 | 14,723 |
Proposal Two: Advisory Compensation Proposal. Our stockholders voted to approve, on a non-binding, advisory basis, certain compensation payments that may be paid or become payable to our named executive officers in connection with the Merger, including severance payments, the accelerated vesting of equity awards and annual bonus payments.
| | | | | | | | |
| For | Against | Abstain |
| 30,422,765 | 1,179,759 | 132,182 |
Proposal Three: Adjournment Proposal. Because there were sufficient votes at the time of the Special Meeting to approve the Merger Proposal, adjournment of the Special Meeting was not necessary or appropriate. Accordingly, Proposal 3 was rendered moot and was not presented at the Special Meeting.
Item 9.01 Financial Statements and Exhibits.
| | | | | |
Exhibit Number | Exhibit |
| |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| | | | | | | | | | | |
| | | SYNAPTICS INCORPORATED |
| | | |
| Date: | November 17, 2026 | By: | /s/ Lisa Bodensteiner |
| | | Lisa Bodensteiner SVP, Chief Legal Officer and Corporate Secretary |